TheraPsil's Proposed Regulations for Medical Psilocybin - Public Consultation Information Webinar скачать в хорошем качестве

TheraPsil's Proposed Regulations for Medical Psilocybin - Public Consultation Information Webinar

TheraPsil, in consultation with patients, lawyers, and regulatory experts have drafted a proposed framework for the legalization of psilocybin for medical and therapeutic purposes. This proposed regulation creates a framework for patients to access medical psilocybin in consultation with a healthcare provider, and access regulated psilocybin products. This framework is based upon the 2016 regulations for medical cannabis in Canada, the Access to Cannabis for Medical Purposes Regulations (ACMPR), and is similarly proposed to be called the ‘APMPR’, or the Access to Psilocybin for Medical Purposes Regulations. TheraPsil invites public consultation and dialogue regarding the first draft of proposed regulations to put forward further recommendations to Health Canada. We hope you will join us in this collaborative process to help Health Canada enact regulations that will make medical psilocybin and psilocybin therapy a safe, effective, equitable, and accessible treatment option in Canada. Our first round of public consultation will end on September 21st, 2021 at 11:59 pm PST. To learn more: https://therapsil.ca/apmpr-first-draf... To view the proposed regulations: https://therapsil.ca/wp-content/uploa... To submit feedback on these regulations: https://docs.google.com/forms/d/e/1FA...